IL1RAP is an immunotherapeutic target for normal karyotype triple-mutated acute myeloid leukemia

IL1RAP exhibits preferential expression within NKt-AML, correlating with diminished overall survival rates and diminished responsiveness to hematopoietic stem cell transplantation. Moreover, internalization of IL1RAP presents a promising avenue for immunotherapeutic intervention.

Authors

Institutions

Publication Details

Journal
Biomarker Research
Published
2025-04-14
DOI
https://doi.org/10.1186/s40364-025-00769-z
Citations
4
Primary Topic
Acute Myeloid Leukemia Research
Type
article
Field-Weighted Citation Impact
7.08

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

IL1RAP is an immunotherapeutic target for normal karyotype triple-mutated acute myeloid leukemia

Albert Feghaly, Marie-Ève Bordeleau, Ossama Moujaber, Richard Marcotte et al.
4 citations
Biomarker Research
Acute Myeloid Leukemia Research
7.08
article

IL1RAP is an immunotherapeutic target for normal karyotype triple-mutated acute myeloid leukemia

Albert Feghaly, Marie-Ève Bordeleau, Ossama Moujaber, Richard Marcotte, Nadine Mayotte, Guy Sauvageau, Véronique Lisi, Guillaume Richard‐Carpentier, Jalila Chagraoui, Josée Hébert, Anna N. Moraitis, Banafsheh Khakipoor, Isabel Boivin, Vincent‐Philippe Lavallée, Geneviève Boucher, Alma Robert, Patrick Gendron, Philippe P. Roux, Jean-François Spinella, Azadeh Hajmirza, Louis Thérêt, Azer Farah, Julie Lippens, Éric Bonneil, François Béliveau, Sébastien Lemieux, Éric Audemard, Léo Aubert, Arnaud Métois, Pierre Thibault
article en
4 citations

Abstract

IL1RAP exhibits preferential expression within NKt-AML, correlating with diminished overall survival rates and diminished responsiveness to hematopoietic stem cell transplantation. Moreover, internalization of IL1RAP presents a promising avenue for immunotherapeutic intervention.

Biomarker ResearchVol. 13(1)
Medical Council of Canada (CA), University of Toronto (CA), Centre Hospitalier Universitaire Sainte-Justine (CA), Princess Margaret Cancer Centre (CA), Hôpital Maisonneuve-Rosemont (CA), Institute for Research in Immunology and Cancer (CA), National Research Council Canada (CA), Université de Montréal (CA)
Genome Canada, Génome Québec, Government of Canada, Stem Cell Network, Université de Montréal, Canada First Research Excellence Fund, Fondation Charles-Bruneau, Institut de Valorisation des Données, Alliance de recherche numérique du Canada, CHU Sainte-Justine Foundation, Canadian Institutes of Health Research, Fonds de Recherche du Québec - Santé
Good health and well-being
Openalex Percentile: Top 3%
Acute Myeloid Leukemia Research
7.08
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.